A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer

Type of Cancer
Gastrointestinal

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.